Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To demonstrate an improvement in progression free survival (PFS) with ZACTIMA™ (ZD6474) 300 mg as compared to Placebo in subjects with advanced or metastatic papillary or follicular Thyroid Carcinoma failing or unsuitable for Radioiodine therapy
Critère d'inclusion
- Carcinoma papilar o folicular de tiroides localmente avanzado o metastásico,Advanced or metastatic papillary or follicular Thyroid Carcinoma